Weronika Maria Schary

Ms. Weronika Maria Schary

Furtwangen University, Furtwangen im Schwarzwald, Baden-Württemberg, Germany
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
AMAdrian Monteleone
Adrian Monteleone
WSWeronika Maria Schary
Weronika Maria Schary
FWFolker Wenzel
Folker Wenzel
HLHeinz Langhals
Heinz Langhals
DDDaniel Dietrich
Daniel Dietrich

25 February 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
WSWeronika Maria Schary
Weronika Maria Schary
FPFilip Paskali
Filip Paskali
SRSimone Rentschler
Simone Rentschler
CRChristoph Ruppert
Christoph Ruppert
GWGabriel E. Wagner
Gabriel E. Wagner
MKMatthias Kohl
Matthias Kohl
Point-of-care (POC) diagnostics, in particular lateral flow assays (LFA), represent a great opportunity for rapid, precise, low-cost and accessible diagnosis of disease. Especially with the ongoing coronavirus disease 2019 (COVID-19) pandemic, rapid point-of-care tests are becoming everyday tools for identification and prevention. Using smartphones as biosensors can enhance POC devices as portable, low-cost platforms for healthcare and medicine, food and environmental monitoring, improving diagnosis and documentation in remote, low-resource locations. We present an open-source, all-in-one smartphone-based system for quantitative analysis of LFAs. It consists of a 3D-printed photo box, a smartphone for image acquisition, and an R Shiny software package with modular, customizable analysis workflow for image editing, analysis, data extraction, calibration and quantification of the assays. This system is less expensive than commonly used hardware and software, so it could prove very beneficial for diagnostic testing in the context of pandemics, as well as in low-resource countries.

13 November 2019 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
PDF file
AMAdrian Monteleone
Adrian Monteleone
WSWeronika Maria Schary
Weronika Maria Schary
AFAndreas Fath
Andreas Fath
FWFolker Wenzel
Folker Wenzel
Although microplastics are commonly defined as very small particles under 5 mm in diameter, they pose an increasingly greater challenge for the environment and all the organisms in it. Particularly, the intake of microplastics into organisms and thei

11 January 2021 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
PDF file
AMAdrian Monteleone
Adrian Monteleone
LBLena Brandau
Lena Brandau
WSWeronika Maria Schary
Weronika Maria Schary
FWFolker Wenzel
Folker Wenzel
INTRODUCTION: More and more researchers are studying the effects of microplastics on the environment and the organisms living in it. Existing detection methods still require a heavy workload, complex sample preparation and high costs. In this study, autofluorescence of plastic was used as a new method for microplastic detection. MATERIAL AND METHODS: Particles of common plastics were incubated at various temperatures (21–230 °C) for different time periods to investigate the influence of these conditions on their autofluorescence using methods like fluorescence microscopy, and measurement of absorption and emission. To give an example of an autofluorescence application, ImageJ was used to determine the contamination of microplastic in sea salt samples. RESULTS: After treatment at 140 °C for 12 h the plastics ABS, PVC and PA showed a distinct increase in their fluorescence intensity. For PET higher temperatures were necessary to achieve higher fluorescence intensities. Using ImageJ, the particle contamination in sea salt samples was determined as 4903±2522 (aluminium membrane) / 5053±2167 (silicone membrane) particles in 10 g salt, which is a much higher number than counted in other publications. DISCUSSION: Probably the increase in fluorescence intensity is due to the movement of atomic bonds caused by the thermic energy during the heat treatment. The high number of counted particles by using ImageJ is most likely based on the smaller pore size of the used filter membranes and other contaminations like dust and fibers, which could be avoided by alternative sample treatment. CONCLUSION: Considering the outcomes of this study, heat treatment is a useful tool to make microplastic particles more visible in microscopic applications without readable destruction of their composition. The heat treatment of plastics for defined incubation times and temperatures can lead to a distinct increase in autofluorescence intensity of the plastics and therefore serve as an easy and cost-effective applicable method for microplastic detection.

30 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MBMatthias Bollinger
Matthias Bollinger
NFNadja Frère
Nadja Frère
ASAlexander Daniel Shapeton
Alexander Daniel Shapeton
WSWeronika Maria Schary
Weronika Maria Schary
MKMatthias Kohl
Matthias Kohl
JRJoachim Risse
Joachim Risse
Early treatment is the mainstay of sepsis therapy. We suspected that early recognition of sepsis by prehospital healthcare providers may shorten the time for antibiotic administration in the emergency department. We retrospectively evaluated all patients above 18 years of age who were diagnosed with sepsis or severe infection in our emergency department between 2018 and 2020. We recorded the suspected diagnosis at the time of presentation, the type of referring healthcare provider, and the time until initiation of antibiotic treatment. Differences between groups were calculated using the Kruskal–Wallis rank sum test. Of the 277 patients who were diagnosed with severe infection or sepsis in the emergency department, an infection was suspected in 124 (44.8%) patients, and sepsis was suspected in 31 (11.2%) patients by referring healthcare providers. Time to initiation of antibiotic treatment was shorter in patients where sepsis or infection had been suspected prior to arrival for both patients with severe infections (p = 0.022) and sepsis (p = 0.004). Given the well-described outcome benefits of early sepsis therapy, recognition of sepsis needs to be improved. Appropriate scores should be used as part of routine patient assessment to reduce the time to antibiotic administration and improve patient outcomes.

28 July 2021
Verified
Dataset
Closed access
FPFilip Paskali
Filip Paskali
WSWeronika Maria Schary
Weronika Maria Schary
MKMatthias Kohl
Matthias Kohl